Cutaneous T-cell Lymphoma Cancercare Connect Education Workshops

- Overview of Diffuse Large B-Cell Lymphoma (DLBCL), in the Context of COVID, Omicron & Seasonal Flu - Staging, Grading & Current Standard of Care - Treatment Options for Relapsed Refractory DLBCL - Bispecific Antibodies for Relapsed Refractory DLBCL - Understanding How Bispecific Antibodies Work in the Treatment of Relapsed Refractory DLBCL - New and Emerging Treatment Approaches - The Role of Clinical Trials - How Research Contributes to Treatment Choices - Tips to Manage Side Effects, Symptoms, Discomfort & Pain - Talking with Your Health Care Team about Quality-of-Life Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts